NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: Insights from the mouse genome

Seminars in Immunology

Volumn 20, Issue 6, 2008, Pages 331-342

  Pyzik, Michal ^a   Kielczewska, Agnieszka ^a   Vidal, Silvia M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cytomegalovirus; Epistasis; Genetics; Innate response; Linkage analysis; Major histocompatibility complex; MHC class I molecules; Mouse model of infection; Natural killer cells; Natural killer gene complex

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD161 ANTIGEN; H2 ANTIGEN; HLA ANTIGEN CLASS 1; LIGAND; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; POLYSACCHARIDE;

ANTIGEN RECOGNITION; C57BL 6 MOUSE; CELL FUNCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE MODEL; EXPERIMENTAL MOUSE; GENE ACTIVATION; GENE CONTROL; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE LOCUS; GENETIC MODEL; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HOST RESISTANCE; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN DOMAIN; PROTEIN SECRETION; REVIEW; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; CYTOMEGALOVIRUS; GENOME; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, NATURAL KILLER CELL;

EID: 56549095214     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2008.09.003     Document Type: Review

References (138)

1. Britt W.J. Human cytomegalovirus infections and mechanisms of disease (2006), Caister Academic Press, Mainz, Germany
2. Sinclair J., and Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol 87 (2006) 1763-1779
3. Nelson C.T., and Demmler G.J. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Perinatol 24 (1997) 151-160
4. Rubin R.H. Cytomegalovirus in solid organ transplantation. Transpl Infect Dis 3 Suppl 2 (2001) 1-5
5. Gandhi M.K., and Khanna R. Human cytomegalovirus clinical aspects immune regulation and emerging treatments. Lancet Infect Dis 4 (2004) 725-738
6. Griffiths P.D. CMV as a cofactor enhancing progression of AIDS. J Clin Virol 35 (2006) 489-492
7. Khan N. The immunological burden of human cytomegalovirus infection. Arch Immunol Ther Exp (Warsz) 55 (2007) 299-308
8. Wang N., Baldi P.F., and Gaut B.S. Phylogenetic analysis, genome evolution and the rate of gene gain in the Herpesviridae. Mol Phylogenet Evol 43 (2007) 1066-1075
9. Gewurz B.E., Gaudet R., Tortorella D., Wang E.W., and Ploegh H.L. Virus subversion of immunity: a structural perspective. Curr Opin Immunol 13 (2001) 442-450
10. Shellam G.R., Allan J.E., Papadimitriou J.M., and Bancroft G.J. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci USA 78 (1981) 5104-5108
11. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
12. Ljunggren H.G., and Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 162 (1985) 1745-1759
13. Daniels B.F., Nakamura M.C., Rosen S.D., Yokoyama W.M., and Seaman W.E. Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain. Immunity 1 (1994) 785-792
14. Lanier L.L. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8 (2008) 259-268
15. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
16. Trowsdale J., and Parham P. Mini-review: defense strategies and immunity-related genes. Eur J Immunol 34 (2004) 7-17
17. Bashirova A.A., Martin M.P., McVicar D.W., and Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7 (2006) 277-300
18. Smith M.G. Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med 86 (1954) 435-440
19. Misra V., and Hudson J.B. Minor base sequence differences between the genomes of two strains of murine cytomegalovirus differing in virulence. Arch Virol 64 (1980) 1-8
20. Krmpotic A., Bubic I., Polic B., Lucin P., and Jonjic S. Pathogenesis of murine cytomegalovirus infection. Microbes Infect 5 (2003) 1263-1277
21. Pollock J.L., and Virgin H.W.T. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol 69 (1995) 1762-1768
22. Kurz S., Steffens H.P., Mayer A., Harris J.R., and Reddehase M.J. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71 (1997) 2980-2987
23. Mercer J.A., and Spector D.H. Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol 57 (1986) 497-504
24. Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Chee M.S., et al. The DNA sequence of the human cytomegalovirus genome. DNA Seq 2 (1991) 1-12
25. Rawlinson W.D., Farrell H.E., and Barrell B.G. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70 (1996) 8833-8849
26. Corbett A.J., Forbes C.A., Moro D., and Scalzo A.A. Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes. J Gen Virol 88 (2007) 758-769
27. Smith L.M., McWhorter A.R., Masters L.L., Shellam G.R., and Redwood A.J. Laboratory strains of murine cytomegalovirus are genetically similar but phenotypically distinct from wild strains of virus. J Virol (2008)
28. Mocarski Jr. E.S. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10 (2002) 332-339
29. Koonin E.V., and Dolja V.V. Evolution of complexity in the viral world: the dawn of a new vision. Virus Res 117 (2006) 1-4
30. Jonjic S., Babic M., Polic B., and Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20 (2008) 30-38
31. Pinto A.K., Munks M.W., Koszinowski U.H., and Hill A.B. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol 177 (2006) 3225-3234
32. Holtappels R., Gillert-Marien D., Thomas D., Podlech J., Deegen P., Herter S., et al. Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol 80 (2006) 7613-7624
33. Cretney E., Degli-Esposti M.A., Densley E.H., Farrell H.E., Davis-Poynter N.J., and Smyth M.J. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J Exp Med 190 (1999) 435-444
34. Natarajan K., Hicks A., Mans J., Robinson H., Guan R., Mariuzza R.A., et al. Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 358 (2006) 157-171
35. Mans J., Natarajan K., Balbo A., Schuck P., Eikel D., Hess S., et al. Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153. J Biol Chem 282 (2007) 35247-35258
36. Orange J.S., and Biron C.A. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 156 (1996) 4746-4756
37. Schneider K., Loewendorf A., De Trez C., Fulton J., Rhode A., Shumway H., et al. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3 (2008) 67-76
38. Dalod M., Salazar-Mather T.P., Malmgaard L., Lewis C., Asselin-Paturel C., Briere F., et al. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195 (2002) 517-528
39. Dalod M., Hamilton T., Salomon R., Salazar-Mather T.P., Henry S.C., Hamilton J.D., et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 197 (2003) 885-898
40. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
41. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101 (2004) 3516-3521
42. Salazar-Mather T.P., Orange J.S., and Biron C.A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 187 (1998) 1-14
43. French A.R., Sjolin H., Kim S., Koka R., Yang L., Young D.A., et al. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol 177 (2006) 4981-4990
44. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169 (2002) 4279-4287
45. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9 (2008) 495-502
46. Andoniou C.E., van Dommelen S.L., Voigt V., Andrews D.M., Brizard G., Asselin-Paturel C., et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 6 (2005) 1011-1019
47. Biron C.A., Byron K.S., and Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320 (1989) 1731-1735
48. Orange J.S. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 4 (2002) 1545-1558
49. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin Immunol 118 (2006) 1-10
50. Bukowski J.F., Woda B.A., and Welsh R.M. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 52 (1984) 119-128
51. Lundberg P., Welander P., Openshaw H., Nalbandian C., Edwards C., Moldawer L., et al. A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. J Virol 77 (2003) 11661-11673
52. Lee S.H., Miyagi T., and Biron C.A. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 28 (2007) 252-259
53. Lanier L.L. NK cell receptors. Annu Rev Immunol 16 (1998) 359-393
54. Chan P.Y., and Takei F. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J Immunol 142 (1989) 1727-1736
55. Yokoyama W.M., Jacobs L.B., Kanagawa O., Shevach E.M., and Cohen D.I. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J Immunol 143 (1989) 1379-1386
56. Colonna M., and Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268 (1995) 405-408
57. Brennan J., Mager D., Jefferies W., and Takei F. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 180 (1994) 2287-2295
58. Karlhofer F.M., Hunziker R., Reichlin A., Margulies D.H., and Yokoyama W.M. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol 153 (1994) 2407-2416
59. Olcese L., Cambiaggi A., Semenzato G., Bottino C., Moretta A., and Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158 (1997) 5083-5086
60. Lanier L.L., Corliss B.C., Wu J., Leong C., and Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391 (1998) 703-707
61. Tormo J., Natarajan K., Margulies D.H., and Mariuzza R.A. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402 (1999) 623-631
62. Dimasi N., Sawicki M.W., Reineck L.A., Li Y., Natarajan K., Margulies D.H., et al. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. J Mol Biol 320 (2002) 573-585
63. Dam J., Guan R., Natarajan K., Dimasi N., Chlewicki L.K., Kranz D.M., et al. Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol 4 (2003) 1213-1222
64. Deng L., Cho S., Malchiodi E.L., Kerzic M.C., Dam J., and Mariuzza R.A. Molecular architecture of the MHC-binding site of Ly49 natural killer cell receptors. J Biol Chem (2008)
65. Makrigiannis A.P., Etzler J., Winkler-Pickett R., Mason A., Ortaldo J.R., and Anderson S.K. Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J Leukoc Biol 68 (2000) 765-771
66. Gorer P.A., Lyman S., and Snell G.D. Studies on the genetic and antigenic basis of tumour translpantation: linkage between a histocompatibility gene and "Fused"in mice. Proc R Soc Lond B135 (1948) 499-505
67. Chalmer J.E., Mackenzie J.S., and Stanley N.F. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37 (1977) 107-114
68. Grundy J.E., Mackenzie J.S., and Stanley N.F. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 32 (1981) 277-286
69. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., and Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171 (1990) 1469-1483
70. Snell G.D., and Higgins G.F. Alleles at the histocompatibility-2 locus in the mouse as determined by tumor transplantation. Genetics 36 (1951) 306-310
71. Kumanovics A., Takada T., and Lindahl K.F. Genomic organization of the mammalian MHC. Annu Rev Immunol 21 (2003) 629-657
72. Kelley J., Walter L., and Trowsdale J. Comparative genomics of major histocompatibility complexes. Immunogenetics 56 (2005) 683-695
73. Bancroft G.J., Shellam G.R., and Chalmer J.E. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol 126 (1981) 988-994
74. Dighe A., Rodriguez M., Sabastian P., Xie X., McVoy M., and Brown M.G. Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol 175 (2005) 6820-6828
75. Scalzo A.A., Lyons P.A., Fitzgerald N.A., Forbes C.A., Yokoyama W.M., and Shellam G.R. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics 27 (1995) 435-441
76. Xie X., Dighe A., Clark P., Sabastian P., Buss S., and Brown M.G. Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My, L-H2b mice and viral downregulation of H-2k class I proteins. J Virol 81 (2007) 229-236
77. Quinnan Jr. G.V., and Manischewitz J.F. Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication. J Virol 61 (1987) 1875-1881
78. Yerkovich S.T., Olver S.D., Lenzo J.C., Peacock C.D., and Price P. The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection. Immunology 91 (1997) 45-52
79. Yokoyama W.M., and Seaman W.E. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 11 (1993) 613-635
80. Hao L., Klein J., and Nei M. Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. Proc Natl Acad Sci USA 103 (2006) 3192-3197
81. Welch A.Y., Kasahara M., and Spain L.M. Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X. Immunogenetics 54 (2003) 782-790
82. Jacoby R.O., Bhatt P.N., and Brownstein D.G. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol 108 (1989) 49-58
83. Schleicher U., Liese J., Knippertz I., Kurzmann C., Hesse A., Heit A., et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med 204 (2007) 893-906
84. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 28 (2001) 42-45
85. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292 (2001) 934-937
86. Adam S.G., Caraux A., Fodil-Cornu N., Loredo-Osti J.C., Lesjean-Pottier S., Jaubert J., et al. Cmv4, a new locus linked to the NK cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice. J Immunol 176 (2006) 5478-5485
87. Scalzo A.A., Manzur M., Forbes C.A., Brown M.G., and Shellam G.R. NK gene complex haplotype variability and host resistance alleles to murine cytomegalovirus in wild mouse populations. Immunol Cell Biol 83 (2005) 144-149
88. Makrigiannis A.P., Patel D., Goulet M.L., Dewar K., and Anderson S.K. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun 6 (2005) 71-83
89. Proteau M.F., Rousselle E., and Makrigiannis A.P. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 84 (2004) 669-677
90. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31 (2002) 429-434
91. Desrosiers M.P., Kielczewska A., Loredo-Osti J.C., Adam S.G., Makrigiannis A.P., Lemieux S., et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 37 (2005) 593-599
92. Depatie C., Lee S.H., Stafford A., Avner P., Belouchi A., Gros P., et al. Sequence-ready BAC contig, physical, and transcriptional map of a 2-Mb region overlapping the mouse chromosome 6 host-resistance locus Cmv1. Genomics 66 (2000) 161-174
93. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., and Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 194 (2001) 29-44
94. Lee S.H., Zafer A., de Repentigny Y., Kothary R., Tremblay M.L., Gros P., et al. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med 197 (2003) 515-526
95. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
96. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99 (2002) 8826-8831
97. Tripathy S.K., Smith H.R., Holroyd E.A., Pingel J.T., and Yokoyama W.M. Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol 80 (2006) 545-550
98. Bubic I., Wagner M., Krmpotic A., Saulig T., Kim S., Yokoyama W.M., et al. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78 (2004) 7536-7544
99. Smith L.M., Shellam G.R., and Redwood A.J. Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 352 (2006) 450-465
100. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R., Yokoyama W.M., et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA 100 (2003) 13483-13488
101. French A.R., Pingel J.T., Wagner M., Bubic I., Yang L., Kim S., et al. Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20 (2004) 747-756
102. Adams E.J., Juo Z.S., Venook R.T., Boulanger M.J., Arase H., Lanier L.L., et al. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci USA 104 (2007) 10128-10133
103. Kielczewska A., Kim H.S., Lanier L.L., Dimasi N., and Vidal S.M. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein. J Immunol 178 (2007) 369-377
104. Davis-Poynter N.J., Degli-Esposti M., and Farrell H.E. Murine cytomegalovirus homologues of cellular immunomodulatory genes. Intervirology 42 (1999) 331-341
105. Silver E.T., Gong D.E., Chang C.S., Amrani A., Santamaria P., and Kane K.P. Ly-49P activates NK-mediated lysis by recognizing H-2Dd. J Immunol 165 (2000) 1771-1781
106. Makrigiannis A.P., Gosselin P., Mason L.H., Taylor L.S., McVicar D.W., Ortaldo J.R., et al. Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol 163 (1999) 4931-4938
107. Makrigiannis A.P., Pau A.T., Saleh A., Winkler-Pickett R., Ortaldo J.R., and Anderson S.K. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol 166 (2001) 5034-5043
108. Hanke T., Takizawa H., McMahon C.W., Busch D.H., Pamer E.G., Miller J.D., et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11 (1999) 67-77
109. Franksson L., Sundback J., Achour A., Bernlind J., Glas R., and Karre K. Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol 29 (1999) 2748-2758
110. Kleijnen M.F., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A.E., et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 16 (1997) 685-694
111. Kane K.P., Silver E.T., and Hazes B. Specificity and function of activating Ly-49 receptors. Immunol Rev 181 (2001) 104-114
112. Rodriguez M., Sabastian P., Clark P., and Brown M.G. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice. J Immunol 173 (2004) 6312-6318
113. Eagle R.A., and Trowsdale J. Promiscuity and the single receptor: NKG2D. Nat Rev Immunol 7 (2007) 737-744
114. Shum B.P., Flodin L.R., Muir D.G., Rajalingam R., Khakoo S.I., Cleland S., et al. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol 168 (2002) 240-252
115. Rodgers J.R., and Cook R.G. MHC class Ib molecules bridge innate and acquired immunity. Nat Rev Immunol 5 (2005) 459-471
116. Gasser S., and Raulet D.H. Activation and self-tolerance of natural killer cells. Immunol Rev 214 (2006) 130-142
117. Voigt S., Mesci A., Ettinger J., Fine J.H., Chen P., Chou W., et al. Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity 26 (2007) 617-627
118. Mesci A., Ljutic B., Makrigiannis A.P., and Carlyle J.R. NKR-P1 biology: from prototype to missing self. Immunol Res 35 (2006) 13-26
119. Yokoyama W.M., and Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 3 (2003) 304-316
120. Plougastel B., Matsumoto K., Dubbelde C., and Yokoyama W.M. Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f. Immunogenetics 53 (2001) 592-598
121. Iizuka K., Naidenko O.V., Plougastel B.F., Fremont D.H., and Yokoyama W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 4 (2003) 801-807
122. Arnon T.I., Markel G., and Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 16 (2006) 348-358
123. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409 (2001) 1055-1060
124. Lopez-Vazquez A., Rodrigo L., Martinez-Borra J., Perez R., Rodriguez M., Fdez-Morera J.L., et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 192 (2005) 162-165
125. Ahlenstiel G., Martin M.P., Gao X., Carrington M., and Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 118 (2008) 1017-1026
126. Stewart-Jones G.B., di Gleria K., Kollnberger S., McMichael A.J., Jones E.Y., and Bowness P. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur J Immunol 35 (2005) 341-351
127. Smyth M.J., Hayakawa Y., Takeda K., and Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2 (2002) 850-861
128. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
129. Giebel S., Locatelli F., Lamparelli T., Velardi A., Davies S., Frumento G., et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102 (2003) 814-819
130. Miller J.S., Cooley S., Parham P., Farag S.S., Verneris M.R., McQueen K.L., et al. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. Blood 109 (2007) 5058-5061
131. Sheridan C. First-in-class cancer therapeutic to stimulate natural killer cells. Nat Biotechnol 24 (2006) 597
132. Iizuka K., Nakajima C., Iizuka Y.M., Takase M., Kato T., Noda S., et al. Protection from lethal infection by adoptive transfer of CD8 T cells genetically engineered to express virus-specific innate immune receptor. J Immunol 179 (2007) 1122-1128
133. Vivier E., Tomasello E., Baratin M., Walzer T., and Ugolini S. Functions of natural killer cells. Nat Immunol 9 (2008) 503-510
134. Carrington M., and Martin M.P. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 298 (2006) 225-257
135. Carrington M., Wang S., Martin M.P., Gao X., Schiffman M., Cheng J., et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 201 (2005) 1069-1075
136. Abi-Rached L., and Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 201 (2005) 1319-1332
137. Barton E.S., White D.W., Cathelyn J.S., Brett-McClellan K.A., Engle M., Diamond M.S., et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447 (2007) 326-329
138. Dam J., Baber J., Grishaev A., Malchiodi E.L., Schuck P., Bax A., et al. Variable dimerization of the Ly49A natural killer cell receptor results in differential engagement of its MHC class I ligand. J Mol Biol 362 (2006) 102-113